SUBBU SARMA, MD
Addiction Medicine (Psychiatry & Neurology) Physician in LEES SUMMIT, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SUBBU SARMA, MD filed 8,631 Medicare Part D claims in 2023 as a Addiction Medicine (Psychiatry & Neurology) Physician in LEES SUMMIT, Missouri.
- 9K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SUBBU SARMA, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
8,631 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
SUBBU SARMA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SUBBU SARMA, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Missouri
How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among Missouri providers
Addiction Medicine (Psychiatry & Neurology) Physician share within Missouri
Addiction Medicine (Psychiatry & Neurology) Physician is one of the more visible NUCC categories in Missouri
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Addiction Medicine (Psychiatry & Neurology) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Addiction Medicine (Psychiatry & Neurology) Physician ABMS/AOA estimate
Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Addiction Medicine (Psychiatry & Neurology) Physician US NPIs
Specialty board-certified rate — Addiction Medicine (Psychiatry & Neurology) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SUBBU SARMA, MD appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider holding MD credentials at 4025 NE LAKEWOOD WAY STE 210, LEES SUMMIT, MO, 64064, with a listed phone of (816) 554-7750. NPI 1689661829 was issued on 10/03/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SARMA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 8,631 prescription claims written by this provider, covering 242 Medicare beneficiaries and totaling roughly $2.3 million in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1689661829 |
|---|---|
| Specialty | Addiction Medicine (Psychiatry & Neurology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/03/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SUBBU SARMA, MD's current license status, disciplinary history, and board certifications with the Missouri Board of Registration for the Healing Arts in Missouri before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where SUBBU SARMA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUBBU SARMA, MD. Source: openpaymentsdata.cms.gov.
Total received
$52.3K
Largest payer
Teva Pharmaceuticals USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,558
- Total Day Supply
- 273,327
- Generic Drug Cost
- $517K
Patient Demographics
- Average Patient Age
- 61.2 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 44% female / 56% male
- Age Distribution
- <65: 127, 65-74: 87, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SUBBU SARMA, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Clozapine
Clozapine
582 claims
- Trazodone Hcl
Trazodone Hcl
511 claims
- Clonazepam
Clonazepam
483 claims
- Benztropine Mesylate
Benztropine Mesylate
415 claims
- Aripiprazole
Aripiprazole
345 claims
- Sertraline Hcl
Sertraline Hcl
298 claims
- Lorazepam
Lorazepam
286 claims
- Risperidone
Risperidone
238 claims
| Drug | Claims |
|---|---|
| Clozapine | 582 |
| Trazodone Hcl | 511 |
| Clonazepam | 483 |
| Benztropine Mesylate | 415 |
| Aripiprazole | 345 |
| Sertraline Hcl | 298 |
| Lorazepam | 286 |
| Risperidone | 238 |
| Quetiapine Fumarate | 229 |
| Fluoxetine Hcl | 197 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Addiction Medicine (Psychiatry & Neurology) Physician Overview
How SUBBU SARMA, MD fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.
SUBBU SARMA, MD's 8,631 claims are above the specialty average of 1,019.
Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as SARMA.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Missouri
Frequently Asked Questions
What is SUBBU SARMA, MD's specialty? ▼
How much does SUBBU SARMA, MD prescribe under Medicare Part D? ▼
Where is SUBBU SARMA, MD located? ▼
What is SUBBU SARMA, MD's NPI number? ▼
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US? ▼
What drugs does SUBBU SARMA, MD prescribe most often? ▼
Does SUBBU SARMA, MD accept Medicare? ▼
How can I verify SUBBU SARMA, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology